faculty.mdanderson.org
Jan 3, 2025, 15:57
High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy – JITC
Journal for ImmunoTherapy of Cancer shared a post on X:
“New JITC article: High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC.”
Authors: Mehmet Altan et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 13, 2025, 09:30
Feb 13, 2025, 09:29
Feb 13, 2025, 09:23
Feb 13, 2025, 09:17
Feb 13, 2025, 09:12
Feb 13, 2025, 09:10
Feb 13, 2025, 09:06
Feb 13, 2025, 08:58
Feb 13, 2025, 08:53
Feb 13, 2025, 08:52